Literature DB >> 15381359

Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid.

Caroline Ryschkewitsch1, Peter Jensen, Jean Hou, Gary Fahle, Steven Fischer, Eugene O Major.   

Abstract

The presence of the human polyomaviruses JCV and BKV in immunocompromised patients can lead to lethal diseases and conditions including progressive multifocal leukoencephalopathy (PML), interstitial nephritis, hemorrhagic cystitis, and kidney allograft rejection. Typically, detection of JCV and BKV in clinical samples has employed standard PCR amplification for viral nucleotide sequences, with subsequent confirmation for viral genome specificity of PCR products by southern blot hybridization. Here, we directly tested a validated PCR-southern protocol with a TaqMan real-time PCR protocol (Applied Biosystems) to assay clinical samples of urine and cerebrospinal fluid. We found equal specificity and sensitivity with both methods. However, real-time allowed for absolute viral-genome quantitation without the use of radionucleotides and was performed more rapidly, in as little as 24 h. Such advantages are important to consider in the effort to establish international standardization of controls for the detection of JCV and BKV, which would aid in screening confidence and the reliable assessment of anti-viral therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381359     DOI: 10.1016/j.jviromet.2004.06.021

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  54 in total

1.  JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.

Authors:  Tom Van Loy; Kim Thys; Caroline Ryschkewitsch; Ole Lagatie; Maria C Monaco; Eugene O Major; Luc Tritsmans; Lieven J Stuyver
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

Authors:  J Kuhle; R Gosert; R Bühler; T Derfuss; R Sutter; O Yaldizli; E-W Radue; C Ryschkewitsch; E O Major; L Kappos; S Frank; H H Hirsch
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

3.  Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.

Authors:  Chen Sabrina Tan; Thomas A Broge; Long Ngo; Sarah Gheuens; Raphael Viscidi; Evelyn Bord; Jacalyn Rosenblatt; Michael Wong; David Avigan; Igor J Koralnik
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-27       Impact factor: 5.742

4.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

5.  Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

Authors:  Moti L Chapagain; Saguna Verma; Frederic Mercier; Richard Yanagihara; Vivek R Nerurkar
Journal:  Virology       Date:  2007-03-30       Impact factor: 3.616

6.  Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Authors:  E Iacobaeus; C Ryschkewitsch; M Gravell; M Khademi; E Wallstrom; T Olsson; L Brundin; Eo Major
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

7.  JC virus-induced Progressive Multifocal Leukoencephalopathy.

Authors:  A Sami Saribas; Ahmet Ozdemir; Cathy Lam; Mahmut Safak
Journal:  Future Virol       Date:  2010-05       Impact factor: 1.831

8.  Multiplex real-time PCR assay for simultaneous quantification of BK polyomavirus, JC polyomavirus, and adenovirus DNA.

Authors:  Yasuhito Funahashi; Seiko Iwata; Yoshinori Ito; Seiji Kojima; Tetsushi Yoshikawa; Ryohei Hattori; Momokazu Gotoh; Yukihiro Nishiyama; Hiroshi Kimura
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  JC virus antibody status underestimates infection rates.

Authors:  Joseph R Berger; Sidney A Houff; Julie Gurwell; Nubia Vega; Craig S Miller; Robert J Danaher
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

10.  Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants.

Authors:  Caroline F Ryschkewitsch; Peter N Jensen; Eugene O Major
Journal:  J Clin Virol       Date:  2013-04-23       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.